Viewing nowGenuine One Olmesartan Tablets 20 Milligrams (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Genuine One Science Co., Ltd.

MFDS item code 201100908 · Approved 2011.02.24 · Insurance code 671703280
Treatment of essential hypertension
Essential hypertension refers to a condition in which blood pressure remains persistently high. This medication helps regulate blood pressure in patients with essential hypertension, thereby reducing the risk of cardiovascular complications. With regular use, blood pressure can be maintained stably, minimizing the impact on daily life. Additionally, it has a protective effect on the heart and blood vessels, making it important for long-term health management. This medication is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
Safety and efficacy in pediatric patients have not been established, and administration is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used by patients with allergies to any of its components, those who are pregnant or breastfeeding, patients undergoing renal dialysis, or those with severe liver disease or biliary obstruction. As it contains lactose, patients with genetic issues such as galactose intolerance should not take this medication. Diabetic patients taking aliskiren products or patients with moderate to severe renal impairment should also avoid this medication. Patients with reduced blood volume or sodium may experience hypotensive symptoms when starting this medication, so caution is advised. Patients with renal impairment or those who have received kidney transplants should have blood potassium and creatinine levels monitored regularly. Patients with unilateral or bilateral renal artery stenosis should be cautious as renal function deterioration may occur. In patients with heart failure or renal impairment, hyperkalemia may occur, so serum potassium levels should be closely monitored. Special care is needed for patients with aortic or mitral valve stenosis, obstructive cardiomyopathy, or hypertrophic cardiomyopathy when taking this medication. It is not recommended for patients with primary aldosteronism as it may have less effect. This medication has a blood pressure-lowering effect that may cause dizziness; therefore, caution should be exercised when performing hazardous activities such as operating machinery or driving. In clinical trials, it mostly showed mild and transient side effects, with dizziness being the most commonly reported. Other reported symptoms include cough, headache, diarrhea, low back pain; however, serious side effects are rare. Rarely, liver function abnormalities, vascular edema, and allergic reactions may occur, and if any unusual symptoms arise, consulting a healthcare professional is necessary. If chronic diarrhea or weight loss occurs during treatment with this medication, this may suggest a gastrointestinal disorder, and a doctor should be contacted immediately. Taking this medication with potassium-sparing diuretics or potassium supplements may dangerously elevate serum potassium levels, so caution is required. When taken in conjunction with other antihypertensives, blood pressure may drop too low, necessitating monitoring. Concurrent use with lithium may increase lithium levels, leading to toxicity; therefore, co-administration is not advisable. Using this medication with non-steroidal anti-inflammatory drugs may impair kidney function, requiring careful monitoring. Taking this medication with other angiotensin-related medications increases the risk of hypotension, hyperkalemia, and renal dysfunction, necessitating thorough observation by healthcare professionals. Pregnant women should avoid this medication due to the risk of fetal harm, and nursing mothers should consider discontinuation of either this medication or breastfeeding due to potential side effects in the infant. The safety of this medication in children has not yet been established. Elderly patients may have increased concentrations of this medication in their bodies; thus, dosage adjustment and caution are necessary. In cases of overdose, hypotension and palpitations may occur, and immediate treatment should be sought if symptoms are present.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it should be kept at room temperature between 1 to 25 degrees Celsius. This storage method helps maintain the medication's effectiveness for a longer period.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Genuine One Science Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.